Waters Corporation

Equities

WAT

US9418481035

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:01 2024-05-07 pm EDT 5-day change 1st Jan Change
326.1 USD +1.94% Intraday chart for Waters Corporation +5.51% -0.96%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Stifel Nicolaus Adjusts Waters Price Target to $332 From $330 MT
Baird Adjusts Waters Price Target to $312 From $319 MT
Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip RE
Barclays Lowers Waters' Price Target to $295 From $300 MT
Evercore IS Adjusts Waters' Price Target to $320 From $340, Keeps In Line Rating MT
Waters Seeks M&A Opportunities CI
Transcript : Waters Corporation, Q1 2024 Earnings Call, May 07, 2024
Waters' Q1 Non-GAAP Earnings, Net Sales Decline; Q2 Outlook Issued MT
Earnings Flash (WAT) WATERS CORPORATION Reports Q1 Revenue $636.8M MT
Earnings Flash (WAT) WATERS CORPORATION Reports Q1 Adjusted EPS $2.21 MT
Waters Corporation Reports Earnings Results for the First Quarter Ended March 30, 2024 CI
Waters Corporation Provides Earnings Guidance for the Second Quarter and Full Year of 2024 CI
Bernstein Adjusts Price Target on Waters to $304 From $307 MT
Baird Adjusts Price Target on Waters to $319 From $315 MT
Waters Corporation Accelerates the Development of Gene-Based Therapeutics with New GTxResolve Premier SEC Columns CI
Leerink Partners Adjusts Waters' Price Target to $338 From $335 MT
Transcript : Waters Corporation Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-04-2024 11:10 AM
Barclays Adjusts Waters Price Target to $300 From $275, Maintains Underweight Rating MT
UBS Adjusts Price Target on Waters to $345 From $285, Maintains Neutral Rating MT
Transcript : Waters Corporation, Q4 2023 Earnings Call, Feb 06, 2024
Waters' Q4 Adjusted Earnings, Net Sales Decline MT
Earnings Flash (WAT) WATERS CORPORATION Posts Q4 Revenue $819.5M MT
Earnings Flash (WAT) WATERS CORPORATION Reports Q4 EPS $3.62 MT
Waters Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Waters Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Chart Waters Corporation
More charts
Waters Corporation specializes in the conception, the manufacturing and the marketing of analytical instruments. Net sales break down by activity as follows: - sale of instruments and analytical systems (63.6%): chromatographic analysis instruments (59.5% of net sales; instruments high performance liquid chromatography and mass spectrometry), chemistry consumables (28.9%; including columns chemical separation) and thermal analysis, rheometry and calorimetry instruments (11.6%) ; - services (36.7%): support services, training, etc. Net sales are distributed by market between pharmaceutical (58.6%), industrial (29.9%), academic institutions and governmental agencies (11.4%). Net sales are distributed geographically as follows: the United States (28.7%), Americas (5.1%), China (17.1%), Japan (7.6%), Asia (13.3%) and Europe (28.2%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
326.1 USD
Average target price
323.7 USD
Spread / Average Target
-0.72%
Consensus
  1. Stock Market
  2. Equities
  3. WAT Stock
  4. News Waters Corporation
  5. Insider Trends: 90-Day Insider Buying Trend at Waters Interrupted with Sale of Shares
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW